\
&
Contact us
\
&
Contact us
Published on | 1 year ago
ProgrammesThe European Commission is looking for success stories and inspirational examples of supervision practice across the Marie Sklodowska-Curie Actions (MSCA) community, to prepare an evidence-based guidance document that will support the existing MSCA guidelines on supervision.
The European Commission has published a survey to gather the examples and stories on the following key themes addressed in the guidelines:
The survey is targeted to researchers and research support personnel who have been involved in MSCA projects. This includes doctoral and postdoctoral fellows, academic and non-academic supervisors, mentors, coaches, administrative and technical staff.
The deadline to share the experience or best practice example is 2 September 2024.
We offer news and event updates, covering all domains and topics of Horizon Europe, Digital Europe & EDF (and occasionally, for ongoing projects, Horizon 2020).
Stay informed about what matters to you.
By signing up, you can opt in for e-mail notifications and get access to
a personalised dashboard that groups all news updates and event announcements in your domain(s).
Only for stakeholders located in Flanders
The METHYLOMIC project, ‘targeting hope for personalised medicine in immune-mediated inflammatory diseases’ obtained funding from Horizon Europe’s Health Cluster. The project aims to personalise treatment allocation and enhance the effectiveness of medications for chronic immune-mediated diseases such as Crohn’s disease, rheumatoid arthritis, and psoriasis. BIRD, the Belgian inflammatory bowel disease research and development group, is a partner in the project and is involved in the OmiCrohn trial, a prospective randomised clinical trial for individualised therapy in Crohn’s disease patients. With BIRD’s active role in this trial, the project is set to deliver predictive, biomarker-based therapies that bring renewed hope for Crohn’s disease patients across Europe.
